DAPAVEL TRIO 1000 MG (Dapagliflozin (10mg) + Metformin (1000mg) + Sitagliptin (100mg))

Dapavel Trio 1000 mg Extended Release Tablet is a medicinal formulation designed to assist in regulating blood glucose levels in individuals diagnosed with type 2 diabetes mellitus. This medication is intended to be used alongside a balanced diet and a routine exercise regimen to enhance glycemic control in adults. Its mechanism involves promoting the effective use of insulin, which consequently helps in reducing elevated blood sugar levels. Patients are advised to take this medication consistently, either with meals or on an empty stomach, ideally at the same time each day to maintain stable blood sugar management. The prescribing healthcare provider will determine the appropriate dosage; therefore, it is crucial not to discontinue use without prior consultation, as doing so could lead to increased blood sugar levels and heightened risks of severe complications, including renal impairment and vision loss. This medication is one component of a comprehensive diabetes management plan that should also emphasize nutritional accountability, regular physical activity, and weight management as directed by a healthcare professional. Staying adequately hydrated while on this medication is important to help mitigate the risk of dehydration and associated complications. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.